Campbell & CO Investment Adviser LLC Gossamer Bio, Inc. Transaction History

Campbell & CO Investment Adviser LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $246,618 - $508,970	34,205 New	34,205 $410,000
Q2 2022 Aug 09, 2022	SELL	$5.97 - $9.97 $68,308 - $114,076	-11,442 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$8.44 - $12.49 $60,413 - $89,403	-7,158 Reduced 38.48%	11,442 $99,000
Q4 2021 Feb 10, 2022	SELL	$10.12 - $14.07 $16,191 - $22,512	-1,600 Reduced 7.92%	18,600 $210,000
Q3 2021 Nov 10, 2021	BUY	$7.25 - $13.23 $146,450 - $267,246	20,200 New	20,200 $254,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.